Janux Therapeutics Inc
Ownership
Ownership Structure
Who owns Janux Therapeutics Inc (JANX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.6% of the shares are freely tradable; institutional investors hold 102.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 18.30 | 11,189,693 | +0.0 | 03/31/2026 |
| BlackRock Inc | 8.89 | 5,433,233 | +33.2 | 03/31/2026 |
| HHG PLC | 6.86 | 4,196,409 | -21.6 | 03/31/2026 |
| Prosight Management, LP | 6.22 | 3,804,481 | +7.2 | 06/30/2026 |
| FMR Inc | 4.15 | 2,535,724 | -27.8 | 03/31/2026 |
| State Street Corp | 4.03 | 2,464,017 | -36.1 | 03/31/2026 |
| Federated Hermes Inc | 3.85 | 2,352,927 | +4,241.2 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.96 | 1,811,365 | +0.0 | 03/31/2026 |
| TCG Crossover Management, LLC | 2.93 | 1,789,617 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.33 | 2,035,185 | -1.1 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Campbell David Alan | President and CEO | 264,742 | 4,474,140 $ | Jul 31, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Campbell David Alan | President and CEO | Other | 123,840 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.